OSLI Retina

May 2019 Supplement

Issue link: http://osliretina.healio.com/i/1115899

Contents of this Issue

Navigation

Page 1 of 27

Ophthalmic Surgery, Lasers & Imaging Retina® (ISSN-2325-8160, Canadian BN-12978 0466 RT ) is published 12 times per year by SLACK Incorporated®, and is an official publication of ARVO/ISIE. Publication Office: SLACK Incorporated®, 6900 Grove Road, Thorofare, NJ 08086-9447. Telephone (856) 848-1000. Printed in the USA. Periodicals Class Postage Paid at Deptford, NJ 08096 and at additional mailing offices. Contents copyrighted by SLACK Incorporated®, 2019. All rights reserved. No part of this publication may be reproduced without prior written consent of the publisher. All requests to reprint or use material published herein should be directed to the Request Permissions link on every article page at Healio.com/ophthalmology/journals/osli. Subscription rates in the U.S. and possessions: Individuals: One year—print $222, electronic only: $197. Institutional: One year—$692. Residents and fellows: $107 for one year (a letter of certification indicating residency of the subscriber is re- quired). Canada add 5% GST, all other countries add $58 per year. All subscriptions, without exception, will start with the first issue published after the order is received. Single copies and back issues, when available, are $96. Payment must accompany order. Subscription requests should be addressed to the publisher. Change of Address: Notice should be sent to the publisher six weeks in advance of effective date. Include old and new addresses with zip codes. The publisher cannot accept responsibility for undelivered copies. Duplicate copies will not be sent to replace ones undelivered through failure to notify the publisher of change of address. POSTMASTER: Send Form 3547 to Ophthalmic Surgery, Lasers & Imaging Retina®, SLACK Incorporated®, 6900 Grove Road, Thorofare, NJ 08086-9447. Articles are intended for informational purposes only and should not be used as the basis of patient treatment. All opinions expressed by authors and quoted sources are their own and do not necessarily reflect the opinions of the editors, publisher, or editorial boards of SLACK Incorporated®. The acceptance of advertising in no way implies endorsement by the editors, publisher, or editorial boards of SLACK Incorporated®. See website for print and web advertising policy. Readers with queries about the Journal's policies on error correction, version control, journal of record, ancillary material, or archiving should contact osli@healio.com. The Journal staff have no financial relationships to disclose. Financial disclo- sures for the Editor and members of the Editorial Board are on file with the editorial office. Indexed in: Medline/PubMed, ProQuest, EMCare, EMBASE, Science Citation Index, Current Contents/Clinical Medicine, BioEngineering Abstracts, CAB Abstracts, and SCOPUS. Follow OSLIJournal OSLI Retina SLACK Incorporated 6900 Grove Road Thorofare, NJ 08086-9447 Phone: 856-848-1000 Email: osli@healio.com Healio.com/OSLIRetina SLACK I N C O R P O R A T E D ® SLACK Incorporated Chief Content Officer Joan-Marie Stiglich, ELS EDITORIAL Senior Editorial Director David W. Mullin Executive Editor Cara Dickinson Production and Circulation Director Cheryl McKeown Production Associate Ryan Davis SPECIAL SERVICES Vice President Christine Martynick Operations Manager Laura Stefano, MA, ELS Project Coordinator Meghan E. McDonald Medical Copy Editor Norma Hanna, ELS SALES Group Sales Director, Eye Care Scott Wright National Account Manager Laura Renna Director, Sales Administration and Support Carolyn Boerner Sales Administrator Wanda Granato Sales Coordinator, Recruitment Jennifer Carroll Director of Audience Development Stephanie McHugh Reprints/Eprints Licensing Opportunities: The Sheridan Press 800-635-7181 ext. 8065 DESIGN Creative Director Thomas Cavallaro The Wyanoke Group President Peter N. Slack Chief Operating Officer John C. Carter Chief Financial Officer Darrell Blood Senior Vice President Denise Mealey Chief Technology Officer Linda Baker Ophthalmology has undergone a revolutionary change in the past 10 years compared with other fields of medi- cine. Therapeutics like anti-vascular endothelial growth fac- tor inhibitors and microsurgical techniques have improved patient outcomes. Caregivers used to hope treatments would reduce the loss of vision over time in conditions such as exu- dative age-related macular degeneration and diabetic retinopa- thy, and now both practitioners and patients expect stability and improvement in vision and anatomy. All of this has been possible because of research. Residents, fellows, and students fuel the engine for scientific progress. They ask bold questions and seek answers. What is the influence of diabetic retinopathy on the visual outcomes after cataract surgery? What is the role of statins and ascorbic acid in the natural history of diabetic retinopathy? What are the retinal changes in migraine, and how do they correlate with duration and severity of disease? These are some of the many questions asked in the 2018 Retina Research Scholar Honoree Program organized by Ophthalmology Times. The goal of this program is to celebrate their research accomplishments, expose them to their peers who are also contributing to the field, and to award those for truly exceptional research. Of the many presentations received, only a select few made it to the oral presentation symposium held just before the American Academy of Ophthalmology 2018 Annual Meeting in Chicago. In this supplement, we highlight five of these presentations. This program would not be possible without support from educational grants from Regeneron Pharmaceuticals and Carl Zeiss Meditec, Inc. On behalf of the judging committee for the Retina Research Scholar Honoree Program, I would like to con- gratulate all participants. We look forward to the presentations in 2019. Rishi P. Singh, MD Cole Eye Institute Cleveland Clinic Foundation Associate Editor, OSLI Retina doi: 10.3928/23258160-20190108-01 Research Developments in the Treatment of Retinal Disease: Finalists From the 2nd Annual Retina Research Scholar Honoree Program

Articles in this issue

Links on this page

Archives of this issue

view archives of OSLI Retina - May 2019 Supplement